AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Amlodipine Besylate USP in Ghana
4 products registered with FDA Ghana — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| AMLOFON 10 TABLETS (Each uncoated tablet contains Amlodipine Besylate USP 10mg) | UNKNOWN-964c43e1 | — | active | 1 May 2031 |
| AMLOFON 5 TABLETS (Each uncoated tablet contains Amlodipine Besylate USP 5mg) | UNKNOWN-96be8068 | — | active | 1 May 2031 |
| AMLOFON 5 TABLETS (Each uncoated tablet contains Amlodipine Besylate USP 5mg) | UNKNOWN-a5b47e42 | — | active | 1 May 2031 |
| AMLOFON 10 TABLETS (Each uncoated tablet contains Amlodipine Besylate USP 10mg) | UNKNOWN-6e58468a | — | active | 1 May 2031 |
Amlodipine Besylate USP — FDA Ghana Registration Details
FDA Ghana (Ghana) has 4 registered products containing Amlodipine Besylate USP, of which 4 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Amlodipine Besylate USP registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.